Strensiq 100 mg

STRENSIQ 100 MG is a subcutaneous solution containing asfotase alfa, used for managing hypophosphatasia. This enzyme replacement therapy is designed to address bone mineralization issues. Learn more about its uses and effects.

STRENSIQ 100 MG is primarily used for the treatment of hypophosphatasia, a rare genetic disorder that affects bone mineralization. Asfotase alfa, the active ingredient, works by replacing the deficient enzyme, helping to improve bone health and function. Patients often seek information on what is STRENSIQ used for, particularly in managing symptoms related to bone fragility and growth issues.

Common effects of STRENSIQ 100 MG may include reactions at the injection site, such as redness, swelling, or itching. Some users might experience systemic effects like fever or fatigue. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

STRENSIQ 100 MG should be handled with care, ensuring proper storage and administration as directed. It is important to follow the prescribed dosage and administration guidelines to minimize the risk of adverse effects. Always consult a healthcare professional before starting or stopping any medication.

STRENSIQ 100 MG may interact with other medications or substances, so it is crucial to inform your healthcare provider about all current medications. Alcohol and certain foods might also affect its efficacy. Always discuss potential interactions with a healthcare professional.